The Role of Cysteine Cathepsins in Cancer Progression and Drug Resistance.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
23 Jul 2019
Historique:
received: 26 06 2019
revised: 17 07 2019
accepted: 19 07 2019
entrez: 26 7 2019
pubmed: 26 7 2019
medline: 28 12 2019
Statut: epublish

Résumé

Cysteine cathepsins are lysosomal enzymes belonging to the papain family. Their expression is misregulated in a wide variety of tumors, and ample data prove their involvement in cancer progression, angiogenesis, metastasis, and in the occurrence of drug resistance. However, while their overexpression is usually associated with highly aggressive tumor phenotypes, their mechanistic role in cancer progression is still to be determined to develop new therapeutic strategies. In this review, we highlight the literature related to the role of the cysteine cathepsins in cancer biology, with particular emphasis on their input into tumor biology.

Identifiants

pubmed: 31340550
pii: ijms20143602
doi: 10.3390/ijms20143602
pmc: PMC6678516
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Proto-Oncogene Proteins c-bcl-2 0
Cathepsins EC 3.4.-

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Russian Science Foundation
ID : 16-15-10410

Références

Biochimie. 2008 Feb;90(2):194-207
pubmed: 17825974
J Pharmacol Exp Ther. 2016 Feb;356(2):375-86
pubmed: 26660229
J Clin Invest. 2000 Nov;106(9):1127-37
pubmed: 11067865
Biochim Biophys Acta. 2009 Apr;1793(4):605-14
pubmed: 19046998
Clin Chim Acta. 2000 Feb 15;291(2):113-35
pubmed: 10675719
Chem Rev. 2002 Dec;102(12):4459-88
pubmed: 12475197
Bone. 1998 Dec;23(6):499-509
pubmed: 9855458
Crit Rev Oral Biol Med. 2002;13(3):238-75
pubmed: 12090464
Hum Pathol. 1999 Jun;30(6):680-6
pubmed: 10374777
Free Radic Res Commun. 1993;18(2):71-85
pubmed: 8386686
Oncogene. 2008 Dec;27 Suppl 1:S93-104
pubmed: 19641510
Clin Cancer Res. 2011 Dec 1;17(23):7337-46
pubmed: 21980135
Bioorg Med Chem. 1999 Feb;7(2):375-9
pubmed: 10218831
J Biol Chem. 1994 Sep 16;269(37):23156-62
pubmed: 8083219
Cancer Res. 2004 Mar 1;64(5):1773-80
pubmed: 14996739
Front Immunol. 2014 Dec 02;5:616
pubmed: 25520721
Clin Cancer Res. 2009 Oct 1;15(19):6042-51
pubmed: 19789302
Oncol Rep. 2015 Apr;33(4):1851-9
pubmed: 25632968
Biochim Biophys Acta. 2012 Jan;1824(1):68-88
pubmed: 22024571
J Biol Chem. 2014 Jun 6;289(23):16239-51
pubmed: 24790080
Mol Pathol. 1999 Dec;52(6):332-40
pubmed: 10748866
Proc Natl Acad Sci U S A. 1978 Jun;75(6):2767-71
pubmed: 351614
Clin Cancer Res. 2000 Mar;6(3):1052-62
pubmed: 10741734
Curr Pharm Des. 2002;8(18):1623-37
pubmed: 12132995
Biol Chem. 2010 Aug;391(8):937-45
pubmed: 20731543
Anticancer Res. 2016 Mar;36(3):1119-26
pubmed: 26977007
Cell Death Differ. 2001 Apr;8(4):324-6
pubmed: 11550083
FEBS Lett. 1990 Aug 20;269(1):189-93
pubmed: 2387401
Biol Chem. 2015 Aug;396(8):867-82
pubmed: 25872877
Cancer Res. 2013 Mar 1;73(5):1524-35
pubmed: 23288510
J Biol Chem. 1996 May 24;271(21):12517-24
pubmed: 8647860
Methods Mol Biol. 2009;539:1-32
pubmed: 19377975
EMBO J. 2001 Sep 3;20(17):4629-33
pubmed: 11532926
Cancer Res. 2004 Jan 1;64(1):27-30
pubmed: 14729603
Genes Chromosomes Cancer. 1998 Nov;23(3):244-7
pubmed: 9790505
Biochem Pharmacol. 2008 Dec 1;76(11):1374-82
pubmed: 18762176
Oxid Med Cell Longev. 2017;2017:3749157
pubmed: 28757908
Mol Cancer. 2009 Aug 28;8:68
pubmed: 19715609
J Biol Chem. 2004 Jan 30;279(5):3578-87
pubmed: 14581476
Medicines (Basel). 2015 Dec;2(4):310-327
pubmed: 27088079
Histopathology. 1995 Jun;26(6):559-64
pubmed: 7665147
Eur J Biochem. 2003 Sep;270(18):3778-86
pubmed: 12950261
Oncol Rep. 2006 Oct;16(4):647-55
pubmed: 16969475
Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8753-62
pubmed: 16361563
Cancer Res. 1998 Feb 1;58(3):432-6
pubmed: 9458085
Anat Rec (Hoboken). 2016 Apr;299(4):428-38
pubmed: 26753874
PLoS One. 2009 Nov 23;4(11):e7953
pubmed: 19956729
Biochimie. 2016 Mar;122:208-18
pubmed: 26343556
Curr Opin Cell Biol. 2016 Apr;39:69-76
pubmed: 26921697
Cancer Lett. 2006 Apr 28;235(2):159-76
pubmed: 15893421
Acta Pharmacol Sin. 2016 Dec;37(12):1606-1622
pubmed: 27840408
Cell Cycle. 2007 Jan 1;6(1):60-4
pubmed: 17245112
Neoplasia. 2008 May;10(5):481-8
pubmed: 18472965
Cancers (Basel). 2019 Jan 19;11(1):
pubmed: 30669448
Oncotarget. 2017 Dec 20;9(18):14084-14098
pubmed: 29581829
Exp Dermatol. 2003 Dec;12(6):761-71
pubmed: 14714555
Theranostics. 2012;2(2):156-78
pubmed: 22400063
Exp Cell Res. 2009 Apr 15;315(7):1234-46
pubmed: 19331819
Biochem J. 1977 Dec 1;167(3):629-37
pubmed: 603625
Cancer Res. 2009 Mar 15;69(6):2260-8
pubmed: 19276390
BMC Cancer. 2016 Sep 29;16(1):762
pubmed: 27687594
Pathol Res Pract. 2005;200(11-12):753-62
pubmed: 15792117
J Biol Chem. 2006 Mar 3;281(9):6020-9
pubmed: 16365041
J Cell Sci. 2016 Dec 1;129(23):4329-4339
pubmed: 27799357
J Biol Chem. 2001 Feb 2;276(5):3149-57
pubmed: 11073962
J Biol Chem. 2007 Mar 16;282(11):7893-902
pubmed: 17227755
PLoS One. 2010 Sep 02;5(9):
pubmed: 20824056
Oncotarget. 2015 Jun 30;6(18):15842-56
pubmed: 26158294
Int J Oncol. 2014 Apr;44(4):1099-106
pubmed: 24452274
J Clin Invest. 2007 Aug;117(8):2095-104
pubmed: 17671649
Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2777-85
pubmed: 20833970
Biochem J. 1990 Jun 1;268(2):287-94
pubmed: 2363674
Expert Opin Ther Targets. 2013 Mar;17(3):281-91
pubmed: 23293836
Int J Oncol. 2003 Jan;22(1):33-9
pubmed: 12469182
Cell Signal. 2018 Apr;44:62-71
pubmed: 29331585
Mol Cell. 2004 Apr 23;14(2):207-19
pubmed: 15099520
Int J Cancer. 2009 Jul 1;125(1):54-61
pubmed: 19291794
Br J Cancer. 2004 May 17;90(10):1961-8
pubmed: 15138478
Biochem Pharmacol. 2005 Jul 1;70(1):161-9
pubmed: 15919056
Int J Cancer. 2010 Apr 15;126(8):1777-1787
pubmed: 19904748
Acta Neuropathol. 1997 May;93(5):494-500
pubmed: 9144588
Biol Chem. 2003 Jun;384(6):891-7
pubmed: 12887056
Oncotarget. 2015 Jan 20;6(2):1143-56
pubmed: 25544758
Biochemistry. 1996 Mar 5;35(9):2811-7
pubmed: 8608115
Cancer Res. 1992 Jul 15;52(14):4000-8
pubmed: 1617677
Nat Rev Cancer. 2015 Dec;15(12):712-29
pubmed: 26597527
Essays Biochem. 2013;55:105-17
pubmed: 24070475
Am J Physiol Cell Physiol. 2009 Jan;296(1):C65-74
pubmed: 18971393
Int J Biochem Cell Biol. 2016 Jan;70:76-81
pubmed: 26589722
Biochim Biophys Acta. 2009 Apr;1793(4):746-54
pubmed: 18948147
Front Pharmacol. 2016 Apr 25;7:107
pubmed: 27199750
Apoptosis. 2010 May;15(5):527-40
pubmed: 20077016
Oncogene. 2009 Aug 6;28(31):2829-38
pubmed: 19503093
Oncotarget. 2017 Jul 11;8(28):45117-45132
pubmed: 28187461
Prostate. 2004 Jul 1;60(2):109-19
pubmed: 15162377
Clin Cancer Res. 2009 Feb 1;15(3):1024-31
pubmed: 19188175
Zhonghua Yan Ke Za Zhi. 2008 Mar;44(3):207-11
pubmed: 18785542
Nat Med. 2013 Jan;19(1):57-64
pubmed: 23202296
Postepy Biochem. 2009;55(2):121-8
pubmed: 19824467
Cancer Lett. 2013 May 28;332(2):265-74
pubmed: 20598437
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2497-502
pubmed: 20133781
Clin Exp Metastasis. 2013 Oct;30(7):891-902
pubmed: 23748470
Int J Biochem. 1993 Apr;25(4):545-50
pubmed: 8467955
Biochem Biophys Res Commun. 1995 Dec 14;217(2):624-31
pubmed: 7503744
Exp Mol Pathol. 2007 Oct;83(2):188-97
pubmed: 17540367
Biochim Biophys Acta. 2012 Jan;1824(1):22-33
pubmed: 21914490
Acta Biochim Pol. 2001;48(1):1-20
pubmed: 11440158
J Clin Invest. 1995 May;95(5):2089-95
pubmed: 7738176
J Clin Invest. 2009 Aug;119(8):2343-58
pubmed: 19662683
Trends Cell Biol. 2000 Aug;10(8):316-21
pubmed: 10884683
Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):716-28
pubmed: 16469948
Auris Nasus Larynx. 1995;22(1):43-8
pubmed: 7677635
Int J Oncol. 2009 Jul;35(1):33-40
pubmed: 19513549
Nat Med. 2005 Feb;11(2):206-13
pubmed: 15665831
Pathol Res Pract. 2014 Dec;210(12):822-9
pubmed: 25442015
J Pathol. 2010 May;221(1):3-12
pubmed: 20225336
Nat Commun. 2014 Jun 04;5:3838
pubmed: 24894568
Hum Pathol. 2005 Sep;36(9):1008-15
pubmed: 16153465
Biomolecules. 2015 Nov 20;5(4):3260-79
pubmed: 26610586
Cancer Res. 1999 Jan 1;59(1):151-8
pubmed: 9892200
Bioimpacts. 2017;7(2):115-133
pubmed: 28752076
J Med Chem. 2000 Feb 10;43(3):305-41
pubmed: 10669559
J Bone Miner Res. 1997 Mar;12(3):447-55
pubmed: 9076588
Cancer Res. 2012 Mar 1;72(5):1199-209
pubmed: 22266111
Cancer Biother Radiopharm. 2006 Jun;21(3):217-24
pubmed: 16918298
J Biol Chem. 2004 Aug 27;279(35):36761-70
pubmed: 15192101
Int J Cancer. 2012 Oct 15;131(8):1779-89
pubmed: 22287159
Oral Oncol. 2003 Sep;39(6):559-68
pubmed: 12798398
Oncotarget. 2017 Apr 24;8(43):73793-73809
pubmed: 29088746
Cell Res. 2012 Sep;22(9):1339-55
pubmed: 22688892
IUBMB Life. 2005 Apr-May;57(4-5):347-53
pubmed: 16036619
Mol Cancer. 2013 Oct 20;12(1):125
pubmed: 24139065
Biochem J. 1998 Nov 1;335 ( Pt 3):491-4
pubmed: 9794785
Biochemistry. 2001 Feb 13;40(6):1671-8
pubmed: 11327826
Biochim Biophys Acta. 2014 Aug;1840(8):2560-70
pubmed: 24680817
J Biol Chem. 2004 Aug 13;279(33):34776-84
pubmed: 15184381
Oncol Rep. 2014 Mar;31(3):1334-42
pubmed: 24402045
Biol Chem. 2001 May;382(5):805-10
pubmed: 11517934
Apoptosis. 2006 Feb;11(2):143-9
pubmed: 16502253
J Biol Chem. 2006 Dec 22;281(51):39588-97
pubmed: 17065156
Front Biosci. 2008 May 01;13:5406-20
pubmed: 18508595
J Control Release. 2017 Jul 10;257:60-67
pubmed: 27908759
Oncogene. 2002 Aug 12;21(35):5462-82
pubmed: 12154408
PLoS One. 2012;7(9):e45910
pubmed: 23029308
J Biol Chem. 1996 Jan 26;271(4):2126-32
pubmed: 8567669
Eur J Cancer. 2000 Apr;36(6):787-95
pubmed: 10762753
J Cancer. 2013;4(1):45-56
pubmed: 23386904
Cancer Lett. 2010 Aug 28;294(2):195-203
pubmed: 20362389
Annu Rev Biochem. 2000;69:303-42
pubmed: 10966461
PLoS One. 2013 Sep 09;8(9):e72882
pubmed: 24039814
Cells. 2019 Mar 20;8(3):
pubmed: 30897858
J Clin Invest. 2010 Oct;120(10):3421-31
pubmed: 20921628
Biochem J. 1992 Feb 15;282 ( Pt 1):273-8
pubmed: 1540143
Lab Invest. 2006 Dec;86(12):1233-42
pubmed: 17043665
J Biol Chem. 2007 Nov 9;282(45):33076-85
pubmed: 17726009
Proc Natl Acad Sci U S A. 1986 Apr;83(8):2483-7
pubmed: 3458210
J Cell Sci. 2005 Apr 1;118(Pt 7):1493-503
pubmed: 15769846
Int J Cancer. 1992 Jan 2;50(1):36-44
pubmed: 1728611
Cancer Res. 2006 May 15;66(10):5216-23
pubmed: 16707446
J Pharmacol Exp Ther. 2006 Jan;316(1):242-7
pubmed: 16174794
J Mol Med (Berl). 2017 Aug;95(8):873-886
pubmed: 28523467
J Pathol. 2005 Sep;207(1):32-42
pubmed: 16025436
Oncol Rep. 1998 Nov-Dec;5(6):1349-61
pubmed: 9769367
J Control Release. 2019 Jan 28;294:376-389
pubmed: 30550940
J Exp Med. 2003 May 19;197(10):1323-34
pubmed: 12756268
Onco Targets Ther. 2017 Apr 03;10:1947-1954
pubmed: 28435284
Clin Chim Acta. 2009 Aug;406(1-2):45-51
pubmed: 19463800
Oncotarget. 2016 Jul 19;7(29):45995-46001
pubmed: 27351223
Cancers (Basel). 2014 Sep 05;6(3):1769-92
pubmed: 25198391
J Cell Sci. 2013 Dec 15;126(Pt 24):5578-84
pubmed: 24127565
Neoplasia. 2013 Oct;15(10):1125-37
pubmed: 24204192
Front Biosci (Landmark Ed). 2009 Jan 01;14(2):453-62
pubmed: 19273077
Biochem Biophys Res Commun. 2010 Jan 1;391(1):1070-4
pubmed: 20004178
Prostate. 2003 Mar 1;54(4):290-8
pubmed: 12539227
Cell Death Dis. 2013 Oct 31;4:e892
pubmed: 24176850
Circulation. 2012 Mar 27;125(12):1551-62
pubmed: 22451605
Biochimie. 2019 Nov;166:233-250
pubmed: 31071357
J Physiol Pharmacol. 2005 Jun;56 Suppl 3:159-79
pubmed: 16077201
Cold Spring Harb Perspect Med. 2013 Jan 01;3(1):a006569
pubmed: 23085847
Biochimie. 2012 Feb;94(2):487-93
pubmed: 21896304
Cell Death Dis. 2017 Apr 6;8(4):e2729
pubmed: 28383558
PLoS One. 2011;6(9):e24967
pubmed: 21966391
Pflugers Arch. 2000 Jan;439(Suppl 1):r122-r123
pubmed: 28176095
Leukemia. 2000 Sep;14(9):1695-703
pubmed: 10995018
J Neurochem. 2009 Sep;110(6):1931-41
pubmed: 19627446
Methods. 2015 Mar;75:128-32
pubmed: 25542097
Oncotarget. 2017 Jun 20;8(25):41690-41700
pubmed: 28402938
Biochim Biophys Acta. 2007 Oct;1774(10):1237-46
pubmed: 17765022
Acta Naturae. 2015 Apr-Jun;7(2):17-28
pubmed: 26085941
J Biol Chem. 2002 Jun 14;277(24):21389-96
pubmed: 11932257
Exp Cell Res. 2006 Aug 1;312(13):2515-27
pubmed: 16774752
J Pathol. 2017 Dec;243(4):496-509
pubmed: 29086922
Eur J Cell Biol. 2012 May;91(5):391-401
pubmed: 22365146
FEBS J. 2005 Mar;272(6):1535-45
pubmed: 15752368
Epigenetics. 2006 Jan-Mar;1(1):32-44
pubmed: 17998816
Oncogene. 2004 Jun 10;23(27):4681-9
pubmed: 15122332
Adv Exp Med Biol. 2000;477:261-70
pubmed: 10849753
Invest New Drugs. 2013 Feb;31(1):20-9
pubmed: 22549440
Biochem Biophys Res Commun. 2008 Aug 22;373(2):292-7
pubmed: 18559255
Free Radic Biol Med. 2003 May 15;34(10):1243-52
pubmed: 12726912
J Biol Chem. 2008 Jul 4;283(27):19140-50
pubmed: 18469004
Haematologica. 2010 Sep;95(9):1452-60
pubmed: 20494937
Clin Cancer Res. 2002 Aug;8(8):2591-4
pubmed: 12171889
Cancer Detect Prev. 2002;26(1):42-9
pubmed: 12088202
Sci Signal. 2014 Sep 23;7(344):re8
pubmed: 25249658

Auteurs

Magdalena Rudzińska (M)

Institute of Molecular Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, Russia.

Alessandro Parodi (A)

Institute of Molecular Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, Russia.

Surinder M Soond (SM)

Institute of Molecular Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, Russia.

Andrey Z Vinarov (AZ)

Institute for Urology and Reproductive Health, Sechenov University, 119992 Moscow, Russia.

Dmitry O Korolev (DO)

Institute for Urology and Reproductive Health, Sechenov University, 119992 Moscow, Russia.

Andrey O Morozov (AO)

Institute for Urology and Reproductive Health, Sechenov University, 119992 Moscow, Russia.

Cenk Daglioglu (C)

Izmir Institute of Technology, Faculty of Science, Department of Molecular Biology and Genetics, 35430 Urla/Izmir, Turkey.

Yusuf Tutar (Y)

Faculty of Pharmacy, University of Health Sciences, 34668 Istanbul, Turkey.

Andrey A Zamyatnin (AA)

Institute of Molecular Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, Russia. zamyat@belozersky.msu.ru.
Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119991 Moscow, Russia. zamyat@belozersky.msu.ru.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH